Cargando…
Decoration of Anti-CD38 on Nanoparticles Carrying a STAT3 Inhibitor Can Improve the Therapeutic Efficacy Against Myeloma
STAT3 is an oncoprotein which has been shown to contribute to drug resistance in multiple myeloma (MM). Nonetheless, the clinical utility of STAT3 inhibitors in treating MM has been limited, partly related to some of their pharmacologic properties. To overcome these challenges, our group had previou...
Autores principales: | Huang, Yung-Hsing, Vakili, Mohammad Reza, Molavi, Ommoleila, Morrissey, Yuen, Wu, Chengsheng, Paiva, Igor, Soleimani, Amir Hasan, Sanaee, Forugh, Lavasanifar, Afsaneh, Lai, Raymond |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407065/ https://www.ncbi.nlm.nih.gov/pubmed/30791634 http://dx.doi.org/10.3390/cancers11020248 |
Ejemplares similares
-
Constitutive Activation of STAT3 in Myeloma Cells Cultured in a Three-Dimensional, Reconstructed Bone Marrow Model
por: Huang, Yung-Hsing, et al.
Publicado: (2018) -
Poly(ethylene glycol)-poly(ε-caprolactone)-based micelles for solubilization and tumor-targeted delivery of silibinin
por: Hassankhani Rad, Ashkan, et al.
Publicado: (2020) -
Development of Self-Associating SN-38-Conjugated Poly(ethylene oxide)-Poly(ester) Micelles for Colorectal Cancer Therapy
por: Sadat, Sams M. A., et al.
Publicado: (2020) -
Three-Dimensional Reconstructed Bone Marrow Matrix Culture Improves the Viability of Primary Myeloma Cells In-Vitro via a STAT3-Dependent Mechanism
por: Huang, Yung-Hsing, et al.
Publicado: (2021) -
Development of Traceable Rituximab-Modified PEO-Polyester
Micelles by Postinsertion of PEG-phospholipids for Targeting of B-cell
Lymphoma
por: Saqr, Asma, et al.
Publicado: (2019)